BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19901964)

  • 1. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells.
    Ribeiro AS; Albergaria A; Sousa B; Correia AL; Bracke M; Seruca R; Schmitt FC; Paredes J
    Oncogene; 2010 Jan; 29(3):392-402. PubMed ID: 19901964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion.
    Davies G; Jiang WG; Mason MD
    Clin Cancer Res; 2001 Oct; 7(10):3289-97. PubMed ID: 11595727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells.
    Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
    Eur Surg Res; 2007; 39(4):208-15. PubMed ID: 17396032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
    Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
    Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-cadherin role in normal breast development and cancer.
    Albergaria A; Ribeiro AS; Vieira AF; Sousa B; Nobre AR; Seruca R; Schmitt F; Paredes J
    Int J Dev Biol; 2011; 55(7-9):811-22. PubMed ID: 22161837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
    Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
    Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3.
    Fuchs M; Hermannstädter C; Specht K; Knyazev P; Ullrich A; Rosivatz E; Busch R; Hutzler P; Höfler H; Luber B
    J Cell Physiol; 2005 Mar; 202(3):805-13. PubMed ID: 15389640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion.
    Chand AL; Herridge KA; Thompson EW; Clyne CD
    Endocr Relat Cancer; 2010 Dec; 17(4):965-75. PubMed ID: 20817789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
    Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
    J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model.
    Ribeiro AS; Sousa B; Carreto L; Mendes N; Nobre AR; Ricardo S; Albergaria A; Cameselle-Teijeiro JF; Gerhard R; Söderberg O; Seruca R; Santos MA; Schmitt F; Paredes J
    J Pathol; 2013 Apr; 229(5):705-18. PubMed ID: 23180380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternatively spliced cadherin-11 enhances human breast cancer cell invasion.
    Feltes CM; Kudo A; Blaschuk O; Byers SW
    Cancer Res; 2002 Nov; 62(22):6688-97. PubMed ID: 12438268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
    Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
    Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
    Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer.
    Jaggi M; Rao PS; Smith DJ; Wheelock MJ; Johnson KR; Hemstreet GP; Balaji KC
    Cancer Res; 2005 Jan; 65(2):483-92. PubMed ID: 15695390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological significance of E-cadherin in an inflammatory breast carcinoma cell line].
    Dong HM; Liu G; Wu J; Lu JS; Luo JM; Shen ZZ; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):4-7. PubMed ID: 16737610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells.
    Shtutman M; Levina E; Ohouo P; Baig M; Roninson IB
    Cancer Res; 2006 Dec; 66(23):11370-80. PubMed ID: 17145883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
    Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
    Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
    Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
    Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.